Literature DB >> 33243431

The relationship between neurofilament light chain and cognition in neurological disorders: A scoping review.

Sanghamithra Ramani1, Jason A Berard2, Lisa A S Walker3.   

Abstract

Neurofilament light chain (NfL) is an emerging biomarker of neural degeneration. NfL is an integral component of axons and is released into the bloodstream and cerebrospinal fluid during neurodegeneration; hence it can be used to monitor disease progression. Given that several neurological disorders are accompanied by cognitive decline, recent literature has investigated the relationship between NfL levels and cognition. The objective of this scoping review was to determine whether a consistent relationship between NfL and cognition exists in the context of variable degrees of neurodegeneration present across several neurological disorders. Four electronic databases were searched for relevant articles and 160 articles were initially identified. After article screening, 37 studies met the final inclusion criteria. Studies were then qualitatively synthesized to determine the relationship between NfL and cognition across a variety of neurological disorders. The large majority of studies found that NfL levels are inversely correlated with cognition, such that higher NfL levels are associated with poorer cognition. This relationship was not universal, however, and this discrepancy was speculated to be due to the nature of the neurological disorder, individual differences between participants, or methodological inconsistencies. Further study is required, and associated recommendations were proposed for the design of future investigations.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cognition; Dementia; Neurodegeneration; Neurofilament light chain; Neuropsychology

Mesh:

Substances:

Year:  2020        PMID: 33243431     DOI: 10.1016/j.jns.2020.117229

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  5 in total

1.  Cardio- and Neurotoxicity of Selected Anti-COVID-19 Drugs.

Authors:  Martin W Nicholson; Ching-Ying Huang; Jyun-Yuan Wang; Chien-Yu Ting; Yu-Che Cheng; Darien Z H Chan; Yi-Chan Lee; Ching-Chuan Hsu; Yu-Hung Hsu; Cindy M C Chang; Marvin L Hsieh; Yuan-Yuan Cheng; Yi-Ling Lin; Chien-Hsiun Chen; Ying-Ta Wu; Timothy A Hacker; Joseph C Wu; Timothy J Kamp; Patrick C H Hsieh
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-20

2.  The cognitive and psychiatric subacute impairment in severe Covid-19.

Authors:  Pedro J Serrano-Castro; Francisco J Garzón-Maldonado; Ignacio Casado-Naranjo; Angela Ollero-Ortiz; Adolfo Mínguez-Castellanos; Mar Iglesias-Espinosa; Pablo Baena-Palomino; Violeta Sánchez-Sanchez; Rosa María Sánchez-Pérez; José Rubi-Callejon; José Carlos Estévez-María; Benito Galeano-Bilbao; Jesús Romero-Imbroda; Beatriz Sobrino; Carlos Arrabal-Gomez; Begoña Oliver-Martos; Luis Muñoz-Becerra; Nerea Requena; María Del Mar González Álvarez de Sotomayor; Guillermo Estivill-Torrus; Juan Suarez; Nicolas Lundahl Ciano-Petersen; Gracia Pons-Pons; Jose Antonio Reyes-Bueno; Pablo Cabezudo-Garcia; Maria José Aguilar-Castillo; Carlos De la Cruz Cosme; María Duque-Holguera; Eva Cuartero-Rodriguez; Rosa María Vilches-Carrillo; Ismael Carrera-Muñoz; Cristóbal Carnero-Pardo; Teresa Ramirez-Garcia; Juan Manuel Oropesa; Ana Dominguez-Mayoral; Nazaret Pelaez-Viñas; Lucia Valiente; Fernando Rodríguez de Fonseca
Journal:  Sci Rep       Date:  2022-03-03       Impact factor: 4.379

3.  Examination of Neurofilament Light Chain Serum Concentrations, Physical Activity, and Cognitive Decline in Older Adults.

Authors:  Pankaja Desai; Klodian Dhana; Charles DeCarli; Robert S Wilson; Elizabeth A McAninch; Denis A Evans; Kumar B Rajan
Journal:  JAMA Netw Open       Date:  2022-03-01

4.  Evaluation of Neurofilament Light Chain as a Biomarker of Neurodegeneration in X-Linked Childhood Cerebral Adrenoleukodystrophy.

Authors:  Hongge Wang; Matthew D Davison; Martin L Kramer; Weiliang Qiu; Tatiana Gladysheva; Ruby M S Chiang; Can Kayatekin; David R Nascene; Leyla A Taghizadeh; Carina J King; Erin E Nolan; Ashish O Gupta; Paul J Orchard; Troy C Lund
Journal:  Cells       Date:  2022-03-07       Impact factor: 6.600

5.  Serum phosphorylated tau protein 181 and neurofilament light chain in cognitively impaired heart failure patients.

Authors:  Jan Traub; Markus Otto; Roxane Sell; Dennis Göpfert; György Homola; Petra Steinacker; Patrick Oeckl; Caroline Morbach; Stefan Frantz; Mirko Pham; Stefan Störk; Guido Stoll; Anna Frey
Journal:  Alzheimers Res Ther       Date:  2022-10-10       Impact factor: 8.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.